These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38919477)

  • 21. [Familial medullary thyroid carcinoma: case report and literature review.].
    Barletta Carrillo CF; Poterico Rojas JA; Barrionuevo Cornejo C; Casavilca Zambrano S; Pinedo Cárdenas A; Quispe Santibañez I; Castro Mujica MDC
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):303-309. PubMed ID: 30734711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma.
    Griebeler ML; Gharib H; Thompson GB
    Endocr Pract; 2013; 19(4):703-11. PubMed ID: 23512389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
    Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes.
    Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N
    J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary medullary thyroid cancer].
    Fendrich V; Zahn A
    Chirurgie (Heidelb); 2023 May; 94(5):393-399. PubMed ID: 36799965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades.
    Hensley SG; Hu MI; Bassett RL; Ying AK; Zafereo ME; Perrier ND; Busaidy NL; Hyde SM; Grubbs EG; Waguespack SG
    J Clin Endocrinol Metab; 2024 Aug; 109(9):2256-2268. PubMed ID: 38441533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
    Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
    Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.
    Boikos SA; Stratakis CA
    Histol Histopathol; 2008 Jan; 23(1):109-16. PubMed ID: 17952863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection.
    Huang Q; Hu A; Zhang M
    BMC Endocr Disord; 2020 May; 20(1):64. PubMed ID: 32408902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Endocrine; 2024 Sep; 85(3):1091-1095. PubMed ID: 39003661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma.
    Heshmati HM; Gharib H; van Heerden JA; Sizemore GW
    Am J Med; 1997 Jul; 103(1):60-9. PubMed ID: 9236487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of medullary thyroid cancer: An overview.
    Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
    Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of medullary thyroid cancer.
    Modigliani E; Franc B; Niccoli-sire P
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):631-49. PubMed ID: 11289739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medullary thyroid cancer - the present state of art].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Frisco NA; Gunn AH; Thomas SM; Stang MT; Scheri RP; Kazaure HS
    Surgery; 2023 Jan; 173(1):260-267. PubMed ID: 36150924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RET oncogene mutations in medullary thyroid carcinoma in Mexican families.
    González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B
    Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.